中國鐵建(601186.SH)下屬聯合體中標146.68億元基礎設施及公共建設配套投資建設項目
格隆匯12月30日丨中國鐵建(601186.SH)公佈,近日,公司下屬中鐵城建集團有限公司、中鐵建城市建設投資有限公司、中鐵第五勘察設計院集團有限公司、中國鐵建大橋工程局集團有限公司聯合體中標張家港高鐵新城(西北片區)基礎設施及公共建設配套投資建設項目工程總承包,工程總承包中標價146.6839億元,中標工期1828日曆天。
項目資金總需求為15億元,項目公司註冊資本金5000萬元,其中張家港市高鐵投資發展有限公司出資500萬元,佔股10%;中鐵建城市建設投資有限公司出資4500萬元,佔股90%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.